When is a "generic" medication not really a generic? confusion about medication products containing the same active ingredient

Journal of Psychosocial Nursing and Mental Health Services

Volumn 48, Issue 2, 2010, Pages 13-16

  Howland, Robert H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CYCLOHEXANOL DERIVATIVE; GENERIC DRUG; PAROXETINE; PSYCHOTROPIC AGENT; VALPROIC ACID; VENLAFAXINE;

ARTICLE; DRUG COST; DRUG LABELING; ECONOMICS; FINANCIAL MANAGEMENT; FOOD AND DRUG ADMINISTRATION; HUMAN; NURSING; ORGANIZATION AND MANAGEMENT; PATIENT SELECTION; PHARMACOKINETICS; PRESCRIPTION; PSYCHIATRIC NURSING; UNITED STATES;

BUPROPION; CYCLOHEXANOLS; DRUG COSTS; DRUG LABELING; DRUG PRESCRIPTIONS; DRUGS, GENERIC; HUMANS; MARKETING OF HEALTH SERVICES; PAROXETINE; PATIENT SELECTION; PSYCHIATRIC NURSING; PSYCHOTROPIC DRUGS; THERAPEUTIC EQUIVALENCY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VALPROIC ACID;

EID: 77949520380     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: 10.3928/02793695-20100108-04     Document Type: Article

References (7)

1. Chenu, F., Batten, L.A., Zernig, G., Ladstaetter, E., Hebert, C., & Blier, P. (2009). Comparison of pharmacokinetic profiles of brand-name and generic formulations of citalopram and venlafaxine: A crossover study. Journal of Clinical Psychiatry, 70, 958-966.
2. Drug Price Competition and Patent Term Restoration Act of 1984, Pub. L. No. 98-417. Retrieved from the Library of Congress website: http://thomas.loc.gov/
3. Howland, R.H. (2009). What makes a generic medication generic? Journal of Psychosocial Nursing and Mental Health Services, 47(12), 17-20.
4. Howland, R.H. (2010). Evaluating the bioavailability and bioequivalence of generic medications. Journal of Psychosocial Nursing and Mental Health Services, 48(1), 13-16.
5. U.S. Food and Drug Administration. (2009a). Approved drug products with therapeutic equivalence evaluations (Orange book) (29th ed.). Retrieved from http://www.fda.gov/Drugs/InformationOnDrugs/ucm129662.htm
6. U.S. Food and Drug Administration. (2009b). Review of therapeutic equivalence generic bupropion XL 300 mg and Wellbutrin XL 300 mg. Retrieved from http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm153270.htm
7. Vergouwen, A.C., & Bakker, A. (2002). Adverse effects after switching to a different generic form of paroxetine: Paroxetine mesylate instead of paroxetine HCl hemihydrate. Nederlands Tijdschrift voor Geneeskunde, 146, 811-812.